Systemic and airways‘ inflammation in healthy subjects of different ages Source: Eur Respir J 2006; 28: Suppl. 50, 671s Year: 2006
Influence of smoking on airway and systemic inflammation in healthy subjects and COPD patients Source: Annual Congress 2010 - Novel mechanisms in COPD Year: 2010
Systemic inflammatory response associated with injury of the respiratory muscles in healthy subjects and COPD patients Source: Eur Respir J 2002; 20: Suppl. 38, 212s Year: 2002
Lung deposition of carmoterol in healthy subjects, patients with asthma and patients with COPD Source: Eur Respir J 2006; 28: Suppl. 50, 211s Year: 2006
A comparison of three different methods for analysing airway resistance in healthy subjects, asthma and chronic obstructive pulmonary disease patients Source: Eur Respir J 2007; 30: Suppl. 51, 177s Year: 2007
Smoking and airway inflammation in asymptomatic subjects and in patients with chronic airway disease Source: Eur Respir J 2002; 20: Suppl. 38, 90s Year: 2002
The lung deposition of tiotropium in COPD patients is comparable to that in healthy subjects and independent of the stage of COPD disease Source: Eur Respir J 2003; 22: Suppl. 45, 51s Year: 2003
Baseline inflammation in the lower airways of allergic rhinitic subjects compared to normal subjects Source: Eur Respir J 2001; 18: Suppl. 33, 270s Year: 2001
Systemic and airway inflammation and the presence of emphysema in patients with COPD Source: Annual Congress 2009 - COPD: from biomarker profiling to clinical assessment Year: 2009
Spatial heterogeneity in regional pulmonary function in COPD patients and healthy young and elderly subjects Source: Annual Congress 2011 - Monitoring with lung function tests in airway diseases Year: 2011
A comparison of muscle dysfunction in patients with chronic obstructive pulmonary disease and healthy subjects Source: International Congress 2018 – Nutrition and metabolic syndrome in COPD Year: 2018
The lower airways microbiome in patients with IPF and COPD Source: International Congress 2019 – Innovations in idiopathic pulmonary fibrosis Year: 2019
Differences in biomarkers of systemic inflammation in two phenotypes of COPD patients Source: Annual Congress 2011 - COPD: human studies Year: 2011
Pulmonary function in children with inflammatory bowel disease do not differ from healthy population Source: Annual Congress 2011 - Paediatric epidemiology: bronchiolitis, pneumonia, asthma and spirometry in non-respiratory conditions Year: 2011
A study of the airway mycobiome in COPD patients and controls Source: International Congress 2019 – Novel molecular pathways in lung cancer and COPD Year: 2019
Systemic inflammation and lung function in young adults Source: Eur Respir J 2006; 28: Suppl. 50, 593s Year: 2006
Airway and systemic inflammation in obese children with asthma Source: Eur Respir J 2013; 42: 1012-1019 Year: 2013
Assessment of nicotine dependence in healthy people and patients with chronic pulmonary obstructive disease or bronchial asthma Source: Eur Respir J 2002; 20: Suppl. 38, 134s Year: 2002
Airways and systemic inflammation and correlation to lung function in smokers and in COPD patients Source: Eur Respir J 2006; 28: Suppl. 50, 651s Year: 2006
Interleukin 18 in the sputum of healthy and COPD smokers: evidence of implication in airway and systemic inflammation Source: Eur Respir J 2007; 30: Suppl. 51, 749s Year: 2007